Metabolomics 2012

代谢组学2012

• 批准号: 8319834
• 负责人: Rima F Kaddurah-Daouk
• 金额: $ 1.05万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-06-01 至 2013-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8319834
• 关键词: Academia; Address; Agreement; Agriculture; Area; Asia; Biochemical; Biological; Biological Markers; Blood Chemical Analysis; Body Fluids; Cardiovascular system; Cells; Chemicals; Cholesterol; Communities; Complement; Country; Data Set; Databases; Development; Diabetes Mellitus; Diagnostic; Disease; Disease Outcome; District of Columbia; Educational workshop; Ensure; Environment; Environmental Risk Factor; Europe; Event; Feedback; Funding; Funding Agency; Future; Genome; Genomics; Glucose; Government Agencies; Growth; Health; Health Status; Human; Individual; Informatics; Institutes; Investments; Lead; Location; Measurement; Measures; Medical; Metabolic; Mission; Monitor; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; Pharmaceutical Preparations; Phenotype; Play; Process; Proteomics; Recruitment Activity; Reporting; Research; Research Personnel; Role; Scientist; Series; Shapes; Site; Societies; Source; Students; Surrogate Markers; Technology; Time; Tissues; Training; Training and Education; Travel; Treatment outcome; United States National Institutes of Health; Washington; cost; drug mechanism; graduate student; insight; interest; meetings; metabolic abnormality assessment; metabolomics; microbiome; new technology; nutrition; prognostic; programs; repository; response; scale up; small molecule; symposium; tool

DESCRIPTION (provided by applicant): Metabolomics, the study of metabolism at a global level, is a rapidly growing field that promises to provide new insights about disease mechanisms and drug effects. New technologies have been developed that enable measurements of hundreds of chemicals that report on disease processes and that can lead to the development of biomarkers that can predict disease or treatment outcomes. Despite early promise, challenges remain before the full potential of metabolomics can be realized. Metabolomics was highlighted as an important area to develop under the NIH roadmap initiative in 2003 and the recent highlighting of metabolomics under the Common Fund initiative within NIH all points to the important role that metabolomics can play within the medical field. The Metabolomics Society was established in 2004 and has played a key role in promoting the field of metabolomics. The society has hosted a series of successful meetings and workshops nationally and internationally that enabled researchers to meet, share progress, and identify bottlenecks limiting rapid progress. In addition, the meetings enabled the training of scientists who wished to join the field. Metabolomics 2012 is the 8th annual meeting for the society which will take place in Washington DC. The Washington Marriott Wardman Park Hotel at 2660 Woodley Road NW, Washington, DC has been selected as site of the 8th annual meeting of the Metabolomics Society and a contractual agreement was established to host the meeting on June 25-28, 2012. For this meeting, we plan to bring together researchers from academia, government agencies, not for profit and for profit organizations to discuss developments in metabolomics technologies and applications and future needs. The timing and location of the meeting will allow the metabolomics community to provide feedback to NIH staff involved in shaping programs under the NIH Common Fund initiatives for scaling up metabolomics capabilities. Key for the mission of the Metabolomics Society is to educate and train young scientists in the field of metabolomics, hence enabling graduate students and postdoctoral research fellows to attend the annual meetings is important and vital for the growth of the field. As in previous years we will seek funding from different sources to support the meeting but in this application to NIH institutes we seek support to cover part of cost of travel and accommodation for invited speakers, students and post doctorate fellows. PUBLIC HEALTH RELEVANCE: Metabolomics, the study of metabolism at a global level, is a rapidly growing field that promises to provide new insights about disease mechanisms and drug effects. The 2012 Metabolomics Society meeting will bring together researchers from academia, government agencies, not for profit and for profit organizations to discuss developments in metabolomics technologies, bottlenecks, applications and future needs. This meeting will also be used to provide education and training to young scientists in order to ensure the continued growth of this important field.

描述（由申请人提供）：代谢组学是全球层面上代谢的研究，是一个快速增长的领域，有望提供有关疾病机制和药物影响的新见解。已经开发了新技术，可以测量数百种有关疾病过程的化学物质，并可以导致可以预测疾病或治疗结果的生物标志物的发展。尽管有早期的承诺，但在实现代谢组学的全部潜力之前，仍然存在挑战。代谢组学被强调为在2003年的NIH路线图计划下发展的重要领域，并且在NIH中，最近对代谢组学在公共基金倡议下对代谢组学在医疗领域内可以发挥的重要作用的重要作用。代谢组学协会成立于2004年，在促进代谢组学领域发挥了关键作用。该协会在国内和国际上举办了一系列成功的会议和研讨会，使研究人员能够见面，共享进度并确定瓶颈限制了快速进步。此外，会议还使希望加入该领域的科学家进行了培训。代谢组学2012年是将在华盛顿特区举行的该协会的第八届年度会议。华盛顿特区伍德利路2660号的华盛顿万豪沃德曼公园酒店已被选为Ansabolomics Society的第八届年度会议的地点，并建立了合同协议，以在2012年6月25日至28日举办会议。对于这次会议，我们计划将学术界的研究人员，政府机构提供利润和应用程序来培养技术和未来的技术，我们计划将其汇集起来。会议的时机和位置将使代谢组学社区能够向参与NIH共同基金计划塑造计划的NIH员工提供反馈，以扩大代谢组学能力。代谢组学协会任务的关键是在代谢组学领域进行教育和培训年轻科学家，因此使研究生和博士后研究人员能够参加年度会​​议，这对于该领域的成长至关重要。就像往年一样，我们将寻求不同来源的资金来支持会议，但是在向NIH机构的申请中，我们寻求支持，以涵盖部分旅行费用和住宿费用，为受邀的演讲者，学生和博士学位研究员提供。 公共卫生相关性：代谢组学是全球层面的代谢研究，是一个快速增长的领域，有望提供有关疾病机制和药物影响的新见解。 2012年代谢组学协会会议将汇集来自学术界，政府机构的研究人员，而不是为了利润和利润组织讨论代谢组学技术，瓶颈，应用和未来需求的发展。这次会议还将用于向年轻科学家提供教育和培训，以确保这一重要领域的持续发展。